Inogen (INGN) EBT Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 1,794.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,794.00 |
| Dec 31, 2025 | -4,074.00 |
| Sep 30, 2025 | 307.00 |
| Jun 30, 2025 | -140.00 |
| Mar 31, 2025 | 978.00 |
| Dec 31, 2024 | 1,555.00 |
| Sep 30, 2024 | -1,415.00 |
| Jun 30, 2024 | -1,960.00 |
| Mar 31, 2024 | -1,578.00 |
| Dec 31, 2023 | -2,866.00 |
| Sep 30, 2023 | -5,140.00 |
| Jun 30, 2023 | -1,707.00 |
| Mar 31, 2023 | -2,590.00 |
| Dec 31, 2022 | 3,710.00 |
| Sep 30, 2022 | -1,849.00 |
| Jun 30, 2022 | -1,680.00 |
| Mar 31, 2022 | -2,414.00 |
| Dec 31, 2021 | -2,572.00 |
| Sep 30, 2021 | -454.00 |
| Jun 30, 2021 | -74.00 |
| Mar 31, 2021 | -1,535.00 |
| Dec 31, 2020 | -1,612.00 |
| Sep 30, 2020 | -1,535.00 |
| Jun 30, 2020 | -892.00 |
| Mar 31, 2020 | -1,323.00 |
| Dec 31, 2019 | -1,684.00 |
| Sep 30, 2019 | -47.00 |
| Jun 30, 2019 | -120.00 |
| Mar 31, 2019 | -118.00 |
| Dec 31, 2018 | -147.00 |
| Sep 30, 2018 | 284.00 |
| Jun 30, 2018 | 196.00 |
| Mar 31, 2018 | 509.00 |
| Dec 31, 2017 | 449.00 |
| Sep 30, 2017 | 95.00 |
| Jun 30, 2017 | 187.00 |
| Mar 31, 2017 | 500.00 |
| Dec 31, 2016 | 1,029.00 |
| Sep 30, 2016 | 588.00 |
| Jun 30, 2016 | 463.00 |
| Mar 31, 2016 | 308.00 |